Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) are recommended in the treatment of arterial hypertension in patients with peripheral arterial disease (PAD). The aims of our study were: (a) to analyse the extent of reinitiation and subsequent discontinuation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wawruch, Martin, Murin, Jan, Tesar, Tomas, Petrova, Miriam, Paduchova, Martina, Celovska, Denisa, Havelkova, Beata, Trnka, Michal, Masarykova, Lucia, Alfian, Sofa D., Aarnio, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953445/
https://www.ncbi.nlm.nih.gov/pubmed/36830904
http://dx.doi.org/10.3390/biomedicines11020368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953445/
https://www.ncbi.nlm.nih.gov/pubmed/36830904
http://dx.doi.org/10.3390/biomedicines11020368

Ejemplares similares